268 related articles for article (PubMed ID: 23313809)
1. Tophaceous gout and high level of hyperuricaemia are both associated with increased risk of mortality in patients with gout.
Perez-Ruiz F; Martínez-Indart L; Carmona L; Herrero-Beites AM; Pijoan JI; Krishnan E
Ann Rheum Dis; 2014 Jan; 73(1):177-82. PubMed ID: 23313809
[TBL] [Abstract][Full Text] [Related]
2. Crystal-proven gout patients have an increased mortality due to cardiovascular diseases, cancer, and infectious diseases especially when having tophi and/or high serum uric acid levels: a prospective cohort study.
Disveld IJM; Zoakman S; Jansen TLTA; Rongen GA; Kienhorst LBE; Janssens HJEM; Fransen J; Janssen M
Clin Rheumatol; 2019 May; 38(5):1385-1391. PubMed ID: 30929152
[TBL] [Abstract][Full Text] [Related]
3. Predictors of Mortality in People with Recent-onset Gout: A Prospective Observational Study.
Vincent ZL; Gamble G; House M; Knight J; Horne A; Taylor WJ; Dalbeth N
J Rheumatol; 2017 Mar; 44(3):368-373. PubMed ID: 27980010
[TBL] [Abstract][Full Text] [Related]
4. Independent and conjoint associations of gout and hyperuricaemia with total and cardiovascular mortality.
Stack AG; Hanley A; Casserly LF; Cronin CJ; Abdalla AA; Kiernan TJ; Murthy BV; Hegarty A; Hannigan A; Nguyen HT
QJM; 2013 Jul; 106(7):647-58. PubMed ID: 23564632
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics of and relationship between metabolic components and renal function among patients with early-onset juvenile tophaceous gout.
Lu CC; Wu SK; Chen HY; Chung WS; Lee MC; Yeh CJ
J Rheumatol; 2014 Sep; 41(9):1878-83. PubMed ID: 25086077
[TBL] [Abstract][Full Text] [Related]
6. Failure to reach uric acid target of <0.36 mmol/L in hyperuricaemia of gout is associated with elevated total and cardiovascular mortality.
Pérez Ruiz F; Richette P; Stack AG; Karra Gurunath R; García de Yébenes MJ; Carmona L
RMD Open; 2019; 5(2):e001015. PubMed ID: 31673414
[TBL] [Abstract][Full Text] [Related]
7. Ultrasonography in the diagnosis of asymptomatic hyperuricemia and gout.
Puig JG; Beltrán LM; Mejía-Chew C; Tevar D; Torres RJ
Nucleosides Nucleotides Nucleic Acids; 2016 Dec; 35(10-12):517-523. PubMed ID: 27906639
[TBL] [Abstract][Full Text] [Related]
8. Associations of Gout and Baseline Serum Urate Level With Cardiovascular Outcomes: Analysis of the Coronary Disease Cohort Study.
Stamp LK; Frampton C; Drake J; Doughty RN; Troughton RW; Richards AM
Arthritis Rheumatol; 2019 Oct; 71(10):1733-1738. PubMed ID: 31162825
[TBL] [Abstract][Full Text] [Related]
9. The risk of clinically diagnosed gout by serum urate levels: results from 30 years follow-up of the Malmö Preventive Project cohort in southern Sweden.
Kapetanovic MC; Nilsson P; Turesson C; Englund M; Dalbeth N; Jacobsson L
Arthritis Res Ther; 2018 Aug; 20(1):190. PubMed ID: 30157929
[TBL] [Abstract][Full Text] [Related]
10. Relationship between serum uric acid and all-cause and cardiovascular mortality in patients treated with peritoneal dialysis.
Xia X; He F; Wu X; Peng F; Huang F; Yu X
Am J Kidney Dis; 2014 Aug; 64(2):257-64. PubMed ID: 24176223
[TBL] [Abstract][Full Text] [Related]
11. Gout: an independent risk factor for all-cause and cardiovascular mortality.
Kuo CF; See LC; Luo SF; Ko YS; Lin YS; Hwang JS; Lin CM; Chen HW; Yu KH
Rheumatology (Oxford); 2010 Jan; 49(1):141-6. PubMed ID: 19933595
[TBL] [Abstract][Full Text] [Related]
12. Urate crystal deposition in asymptomatic hyperuricaemia and symptomatic gout: a dual energy CT study.
Dalbeth N; House ME; Aati O; Tan P; Franklin C; Horne A; Gamble GD; Stamp LK; Doyle AJ; McQueen FM
Ann Rheum Dis; 2015 May; 74(5):908-11. PubMed ID: 25637002
[TBL] [Abstract][Full Text] [Related]
13. Exploratory study of radiographic change in patients with tophaceous gout treated with intensive urate-lowering therapy.
Dalbeth N; Doyle AJ; McQueen FM; Sundy J; Baraf HS
Arthritis Care Res (Hoboken); 2014 Jan; 66(1):82-5. PubMed ID: 23836458
[TBL] [Abstract][Full Text] [Related]
14. A pilot study on dual-energy computed tomography for detection of urate deposits in renal transplant patients with asymptomatic hyperuricemia.
Kimura-Hayama E; Criales-Vera S; Nicolaou S; Betanzos JL; Rivera Y; Alberú J; Rull-Gabayet M; Hernández-Molina G
J Clin Rheumatol; 2014 Sep; 20(6):306-9. PubMed ID: 25160012
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of plain radiography for assessing hypouricemic treatment response in patients with tophaceous gout.
Suh YS; Cheon YH; Kim JE; Kim JM; Kim SH; Lee WS; Yoo WH; Lee SI; Kim HO
Int J Rheum Dis; 2016 Nov; 19(11):1183-1188. PubMed ID: 27514938
[TBL] [Abstract][Full Text] [Related]
16. Long-term cardiovascular mortality among middle-aged men with gout.
Krishnan E; Svendsen K; Neaton JD; Grandits G; Kuller LH;
Arch Intern Med; 2008 May; 168(10):1104-10. PubMed ID: 18504339
[TBL] [Abstract][Full Text] [Related]
17. Asymptomatic hyperuricemia is not an independent risk factor for cardiovascular events or overall mortality in the general population of the Busselton Health Study.
Nossent J; Raymond W; Divitini M; Knuiman M
BMC Cardiovasc Disord; 2016 Dec; 16(1):256. PubMed ID: 27978810
[TBL] [Abstract][Full Text] [Related]
18. Relationship between structural joint damage and urate deposition in gout: a plain radiography and dual-energy CT study.
Dalbeth N; Aati O; Kalluru R; Gamble GD; Horne A; Doyle AJ; McQueen FM
Ann Rheum Dis; 2015 Jun; 74(6):1030-6. PubMed ID: 24521739
[TBL] [Abstract][Full Text] [Related]
19. A gender-specific analysis of association between hyperuricaemia and cardiovascular events in patients with coronary artery disease.
Ndrepepa G; Cassese S; Braun S; Fusaro M; King L; Tada T; Schömig A; Kastrati A; Schmidt R
Nutr Metab Cardiovasc Dis; 2013 Dec; 23(12):1195-201. PubMed ID: 24099726
[TBL] [Abstract][Full Text] [Related]
20. Association between serum urate, gout and comorbidities: a case-control study using data from the UK Biobank.
Sandoval-Plata G; Nakafero G; Chakravorty M; Morgan K; Abhishek A
Rheumatology (Oxford); 2021 Jul; 60(7):3243-3251. PubMed ID: 33313843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
